The stock of Vertex Inc (VERX) has gone down by -7.64% for the week, with a -1.54% drop in the past month and a 17.39% rise in the past quarter. The volatility ratio for the week is 1.60%, and the volatility levels for the past 30 days are 1.88% for VERX. The simple moving average for the past 20 days is -4.07% for VERX’s stock, with a -13.58% simple moving average for the past 200 days.
Is It Worth Investing in Vertex Inc (NASDAQ: VERX) Right Now?
The 36-month beta value for VERX is at 0.75. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 6 rating it as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for VERX is 63.75M, and currently, shorts hold a 8.40% of that float. The average trading volume for VERX on June 10, 2025 was 1.12M shares.
VERX) stock’s latest price update
Vertex Inc (NASDAQ: VERX)’s stock price has gone decline by -7.20 in comparison to its previous close of 40.67, however, the company has experienced a -7.64% decrease in its stock price over the last five trading days. businesswire.com reported 2025-06-06 that BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s E.
Analysts’ Opinion of VERX
Many brokerage firms have already submitted their reports for VERX stocks, with Exane BNP Paribas repeating the rating for VERX by listing it as a “Outperform.” The predicted price for VERX in the upcoming period, according to Exane BNP Paribas is $54 based on the research report published on April 22, 2025 of the current year 2025.
Stifel, on the other hand, stated in their research note that they expect to see VERX reach a price target of $31, previously predicting the price at $58. The rating they have provided for VERX stocks is “Hold” according to the report published on February 28th, 2025.
VERX Trading at -2.31% from the 50-Day Moving Average
After a stumble in the market that brought VERX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -37.84% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at VERX starting from Jeffrey Westphal, who proposed sale 3,000,000 shares at the price of $41.07 back on Jun 09 ’25. After this action, Jeffrey Westphal now owns shares of Vertex Inc, valued at $123,210,000 using the latest closing price.
Leib Ryan J, the Chief Accounting Officer of Vertex Inc, sale 5,755 shares at $38.00 during a trade that took place back on May 13 ’25, which means that Leib Ryan J is holding 0 shares at $218,690 based on the most recent closing price.
Stock Fundamentals for VERX
Current profitability levels for the company are sitting at:
- 0.0 for the present operating margin
- 0.64 for the gross margin
The net margin for Vertex Inc stands at -0.06. The total capital return value is set at 0.01. Equity return is now at value -19.65, with -4.64 for asset returns.
Based on Vertex Inc (VERX), the company’s capital structure generated 0.64 points at debt to capital in total, while cash flow to debt ratio is standing at 0.44. The debt to equity ratio resting at 1.75. The interest coverage ratio of the stock is 18.87.
Currently, EBITDA for the company is 102.01 million with net debt to EBITDA at 1.07. When we switch over and look at the enterprise to sales, we see a ratio of 8.79. The receivables turnover for the company is 4.51for trailing twelve months and the total asset turnover is 0.6. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.98.
Conclusion
In conclusion, Vertex Inc (VERX) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
